BIOPATH.MED: what changed
BIOPATH.MED
Largest movements
- Current investments -€100,000
down €100,000 (-18.2%), from €550,000 to €450,000
- Cash +€59,420
up €59,420 (+117%), from €50,957 to €110,378
mainly Current investments (+€100,000) and Deferred charges and accrued income (+€8,746)
- Deferred charges and accrued income -€8,746
down €8,746 (-74.1%), from €11,805 to €3,059
- Other debts -€32,840
down €32,840 (-96.9%), from €33,898 to €1,058
- Profit (loss) carried forward -€10,505
down €10,505 (-60.3%), from -€17,418 to -€27,923
- Reserves -€7,228
down €7,228 (-1.3%), from €577,751 to €570,523
of which Distributable reserves: -€7,228
- Financial income -€17,145
down €17,145 (-62.0%), from €27,632 to €10,487
- Taxes -€3,799
down €3,799 (-86.0%), from €4,418 to €619
- Gross operating margin -€2,960
down €2,960 (-19.9%), from -€14,862 to -€17,822
- Other operating charges -€385
down €385 (-18.1%), from €2,129 to €1,744
- Financial charges +€379
up €379 (+88.4%), from €428 to €807
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €617,477 | €569,374 | -€48,103 | -7.8% |
| Fixed assets | 21/28 | €0 | - | = | |
| Tangible fixed assets | 22/27 | €0 | - | = | |
| Furniture and vehicles | 24 | €0 | - | = | |
| Current assets | 29/58 | €617,477 | €569,374 | -€48,103 | -7.8% |
| Amounts receivable within one year | 40/41 | €4,715 | €5,938 | +€1,223 | +25.9% |
| Trade receivables | 40 | - | €3,411 | +€3,411 | |
| Other amounts receivable | 41 | €4,715 | €2,527 | -€2,187 | -46.4% |
| Current investments | 50/53 | €550,000 | €450,000 | -€100,000 | -18.2% |
| Cash at bank and in hand | 54/58 | €50,957 | €110,378 | +€59,420 | +117% |
| Deferred charges and accrued income | 490/1 | €11,805 | €3,059 | -€8,746 | -74.1% |
| Total equity and liabilities | 10/49 | €617,477 | €569,374 | -€48,103 | -7.8% |
| Equity | 10/15 | €578,934 | €561,200 | -€17,733 | -3.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €577,751 | €570,523 | -€7,228 | -1.3% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €577,751 | €570,523 | -€7,228 | -1.3% |
| Profit (loss) carried forward | 14 | -€17,418 | -€27,923 | -€10,505 | -60.3% |
| Amounts payable | 17/49 | €38,543 | €8,174 | -€30,369 | -78.8% |
| Amounts payable within one year | 42/48 | €38,543 | €8,174 | -€30,369 | -78.8% |
| Trade debts | 44 | €3,370 | €5,479 | +€2,109 | +62.6% |
| Suppliers | 440/4 | €3,370 | €5,479 | +€2,109 | +62.6% |
| Taxes, remuneration and social security | 45 | €1,275 | €1,636 | +€361 | +28.3% |
| Taxes | 450/3 | €0 | €361 | +€361 | |
| Remuneration and social security | 454/9 | €1,275 | €1,275 | = | 0.0% |
| Other amounts payable | 47/48 | €33,898 | €1,058 | -€32,840 | -96.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €76 | €0 | -€76 | -100% |
| Other operating charges | 640/8 | €2,129 | €1,744 | -€385 | -18.1% |
| Gross operating margin | 9900 | -€14,862 | -€17,822 | -€2,960 | -19.9% |
| Operating profit (loss) | 9901 | -€17,067 | -€19,566 | -€2,499 | -14.6% |
| Financial income | 75/76B | €27,632 | €10,487 | -€17,145 | -62.0% |
| Recurring financial income | 75 | €27,632 | €10,487 | -€17,145 | -62.0% |
| Financial charges | 65/66B | €428 | €807 | +€379 | +88.4% |
| Recurring financial charges | 65 | €428 | €807 | +€379 | +88.4% |
| Profit (loss) for the period before taxes | 9903 | €10,136 | -€9,886 | -€20,023 | |
| Income taxes | 67/77 | €4,418 | €619 | -€3,799 | -86.0% |
| Profit (loss) for the period | 9904 | €5,719 | -€10,505 | -€16,224 | |
| Profit (loss) for the period to be appropriated | 9905 | €5,719 | -€10,505 | -€16,224 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.